A stage-four cancer diagnosis once sounded like the end of the road – after all, there is no stage five. When Joe Biden’s ...

Discover the future of Canada's Oncology Market with our comprehensive "Canada Oncology Market Outlook to 2033" report. Covering key segments like Colorectal Cancer and PD-L1 tests, it includes ...

The Cancer Immunotherapy market, valued at USD 220.94 billion in 2024, is expected to register robust revenue CAGR of 13.6%.

DelveInsight’s, “Glioma Pipeline Insight, 2025” report provides comprehensive insights about 180+ companies and 200+ pipeline ...

CAMBRIDGE, MA, USA I July 21, 2025 I Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on ...

A Food and Drug Administration expert panel has reignited a debate over whether hormone therapy should be used to treat ...

The Precision Era of medicine is arriving in Asia Pacific, driven by the arrival of a critical mass of innovative ...

Using data from the T2T reference, scientists linked two new genes to changes in brain size and synapse signaling.

What makes the human brain distinctive? A new study published July 21 in Cell identifies two genes linked to human brain features and provides a road map to discover many more. The research could lead ...

FDA fast-tracks DB-1310, a novel HER3-targeting ADC, offering hope for advanced NSCLC patients with unmet treatment needs.